| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GRI Bio, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 103,067 | $88,956 | $0.6857 | 18 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRI | GRI Bio, Inc. | 18 Sep 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 22 Sep 2025, 16:05 |
| GRI | GRI Bio, Inc. | 26 Aug 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 27 Aug 2025, 08:25 |
| GRI | GRI Bio, Inc. | 23 Jan 2025 | 1 | +$88,956 | 4 | Chief Executive Officer, Director | 24 Jan 2025, 17:58 |
| GRI | GRI BIO, Inc. | 21 Apr 2023 | 0 | $0 | 3 | Chief Executive Officer, Director, 10%+ Owner | 25 Apr 2023, 13:50 |
| GRI | GRI BIO, Inc. | 21 Apr 2023 | 1 | $0 | 4 | Chief Executive Officer, Director, 10%+ Owner | 24 Apr 2023, 18:30 |